daBoze, we are constructing a railway that will take FluCide to the Clinical Trials in Australia (2015) and ultimately to FDA review/market. However, FluCide GLP full tox study, is the one station in which the "train of therapeutic drugs" will not be slowing down or stopping for again. The BigKahuna explains...
Every key step/milestone that is realized will reassure investors and should be accompanied by a rise in pps. I'd like to think $30 pps by Christmas. People will say not possible. If we are successful, effective, with the EbolaCide candidate I would say higher than $30.
Drugs to FDA review/market will move faster and with it the climb in pps.